Blue Note Therapeutics Raises $26.25 Million in Series A Financing
05 Mar, 2021
– Sentry has raised $60m in a series D round of funding led by Andreessen Horowitz, with participation from existing investors Benchmark, Index Ventures, and Union Square Ventures.
– The company is now valued at $1bn.
– Application performance monitoring startup Sentry today announced it has secured $60 million in series D financing for a post-money valuation of $1 billion.
– Sentry says the funds will fuel product development and go-to-market functions, as well as hiring across the company’s San Francisco, Toronto, and Vienna offices.